AstraZeneca heart drug gets preferred status in U.S.
October 06, 2014 at 07:30 AM EDT
LONDON, Oct 6 (Reuters) - AstraZeneca's blood-thinning drug Brilinta has won preferred status in the United States, where two medical groups have recommended it over the older drug Plavix, also known as clopidogrel.
